BMD

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1402459
                    [Title] => Rule out secondary causes of osteoporosis
                    [Summary] => 
Before initiating osteoporosis therapy on the basis of a T score, investigate any correctable cases of secondary osteoporosis, urged the University of California, San Francisco.

                    [DatePublished] => 2014-12-14 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 825619
                    [Title] => Visceral obesity linked to osteoporosis before menopause
                    [Summary] => 
Visceral obesity was associated with low bone mineral density in a study of premenopausal women, indicating that abdominal fat is a risk factor for osteoporosis.
                    [DatePublished] => 2012-07-08 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 369095
                    [Title] => Osteoporosis Treatment: Study assesses long-term efficacy of ibandronic acid
                    [Summary] => 

New findings from the first year of a study assessing the long-term efficacy of ibandronic acid, the first and only once-monthly bishophonate indicated for the treatment of osteoporosis in women, show that the drug "continues to be highly effective at strengthening bone in the spine and hip by increasing bone mineral density (BMD)."


The Monthly Oral iBandronate in Ladies Long Term Extension (MOBILE LTE) study also shows ibandronic acid as well tolerated over a three-year period.


                    [DatePublished] => 2006-11-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 285377
                    [Title] => Bone mineral density test no longer enough, say experts
                    [Summary] => Geneva, Switzerland — The Alliance for Better Bone Health has announced that according to evidence presented by an international panel of osteoporosis experts, Bone Mineral Density (BMD) testing does not accurately reflect all factors important to bone strength. 


                    [DatePublished] => 2005-07-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Rule out secondary causes of osteoporosis

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | December 14, 2014 - 12:00am

Before initiating osteoporosis therapy on the basis of a T score, investigate any correctable cases of secondary osteoporosis, urged the University of California, San Francisco.

Opinion

Visceral obesity linked to osteoporosis before menopause

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | July 8, 2012 - 12:00am

Visceral obesity was associated with low bone mineral density in a study of premenopausal women, indicating that abdominal fat is a risk factor for osteoporosis.

Opinion

Osteoporosis Treatment: Study assesses long-term efficacy of ibandronic acid

November 16, 2006 - 12:00am

New findings from the first year of a study assessing the long-term efficacy of ibandronic acid, the first and only once-monthly bishophonate indicated for the treatment of osteoporosis in women, show that the...

Science and Environment

Bone mineral density test no longer enough, say experts

July 7, 2005 - 12:00am

Geneva, Switzerland — The Alliance for Better Bone Health has announced that according to evidence presented by an international panel of osteoporosis experts, Bone Mineral Density (BMD) testing does not accurately...

Science and Environment